Gene Mutation May Explain Why Some Don’t Get Sick from COVID-19
A common mutation can help people infected with the COVID-19 virus avoid developing any symptoms.
University of California San Francisco
Give to UCSF
Commentary: New Class of Drugs Shifts Momentum on Alzheimer’s
A new Alzheimer’s drug is expected to be approved by the Food and Drug Administration (FDA). However, the medication works best mostly for those in the earliest stages of Alzheimer’s.
COVID-19 Vaccines Saved Dementia Patients’ Lives in Nursing Homes
Deaths among older adults with dementia fell starkly in nursing homes and long-term care centers after COVID-19 vaccinations became available, but remained high for those living at home.
Don’t Take Chances: Why Doxycycline is a Great Bet Against STIs
A short course of antibiotics, Doxy-PEP, can prevent some STIs after condomless sex.
Newborn Screening is Biggest Factor in ‘Bubble Baby Disease’ Survival in Last 40 Years
A new study shows that newborn screening for SCID is the only factor that actually boosts survival rates.
Brains and Braggadocio
As part of its miniseries on Black excellence in STEM, Carry the One Radio interviewed UCSF’s Akinyemi Oni-Orisan, PharmD, PhD. The assistant professor of clinical pharmacy shares how he’s improving cardiovascular care for everyone and how he inspires confidence in himself and his students. Find it on your favorite podcast forum.
The Truth About Dietary Supplements
Drawing on her decades of research and clinical experience, Mahtab Jafari, PharmD ’94, a professor of pharmaceutical sciences at UC Irvine, sheds light on the largely unregulated supplement industry and empowers readers to make choices informed by science.
What’s New in the Search for a Long COVID Cure?
UCSF infectious disease specialist Michael Peluso, MD, who co-leads one of the world’s oldest studies of long COVID, discusses the condition’s mysteries.
Calling All Scientists to Fight the Next Pandemic
UCSF’s Nevan Krogan, PhD, is taking aim at the world’s deadliest diseases by uniting scientists and the biomedical industry to speed treatments.
How Gene Therapy Saved a Child from ‘Bubble Boy’ Disease
In a breakthrough, “HT” became the first person in the world to receive gene-corrected stem cells for Artemis-SCID.
